Q

Quoin Pharmaceuticals Ltd
NASDAQ:QNRX

Watchlist Manager
Quoin Pharmaceuticals Ltd
NASDAQ:QNRX
Watchlist
Price: 9.55 USD -0.52% Market Closed
Market Cap: $5.7m

Relative Value

QNRX doesn't have a meaningful market cap.

There is not enough data to reliably calculate the relative value of QNRX.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

QNRX Relative Value
Base Case
Not Available
Worst Case
Base Case
Best Case

Multiples Across Competitors

QNRX Competitors Multiples
Quoin Pharmaceuticals Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
IL
Quoin Pharmaceuticals Ltd
NASDAQ:QNRX
5.8m USD 0 -0.4 -0.2 -0.2
US
PerkinElmer Inc
LSE:0KHE
1.3T USD 460.4 5 453.9 1 599.2 3 212.8
US
Thermo Fisher Scientific Inc
NYSE:TMO
238.1B USD 5.4 36.2 25.6 33.1
US
Danaher Corp
NYSE:DHR
167.3B USD 6.9 47.8 25.6 38.6
KR
Samsung Biologics Co Ltd
KRX:207940
83T KRW 15.1 52 30.6 40.8
CH
Lonza Group AG
SIX:LONN
37.8B CHF 5.4 52.1 39.3 39.3
US
IQVIA Holdings Inc
NYSE:IQV
40.5B USD 2.5 31.6 15.2 22.7
CN
WuXi AppTec Co Ltd
SSE:603259
274.9B CNY 6.3 18.7 18.7 18.7
US
Agilent Technologies Inc
NYSE:A
38.4B USD 5.5 29.6 22.9 27.3
US
Mettler-Toledo International Inc
NYSE:MTD
29.1B USD 7.4 34.9 25.1 27.9
FR
Sartorius Stedim Biotech SA
PAR:DIM
20.3B EUR 6.9 77.3 27.3 44.9
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
IL
Q
Quoin Pharmaceuticals Ltd
NASDAQ:QNRX
Average EV/EBITDA: 182.9
Negative Multiple: -0.2
N/A N/A
US
P
PerkinElmer Inc
LSE:0KHE
1 599.2
5%
319.8
US
Thermo Fisher Scientific Inc
NYSE:TMO
25.6
6%
4.3
US
Danaher Corp
NYSE:DHR
25.6
5%
5.1
KR
Samsung Biologics Co Ltd
KRX:207940
30.6
20%
1.5
CH
Lonza Group AG
SIX:LONN
39.3
18%
2.2
US
IQVIA Holdings Inc
NYSE:IQV
15.2
8%
1.9
CN
WuXi AppTec Co Ltd
SSE:603259
18.7
30%
0.6
US
Agilent Technologies Inc
NYSE:A
22.9
14%
1.6
US
Mettler-Toledo International Inc
NYSE:MTD
25.1
4%
6.3
FR
Sartorius Stedim Biotech SA
PAR:DIM
27.3
19%
1.4